Case Report Dentistry Endocrinology/Diabetes/Metabolism Pharmacology
Rethinking medication adherence in adults with type 2 diabetes: the role of early enteral nutrition

Rethinking medication adherence in adults with type 2 diabetes: the role of early enteral nutrition

Authors

Mateo Lindqvist

Mateo Lindqvist

Aga Khan University Hospital, Ecuador

Karim Andersen

Karim Andersen

Karolinska University Hospital, Canada

Corresponding

Published

August 13, 2024

Paper ID

PAP-000179

Status

Published

DOI

10.65712/tmj.test000437

Rethinking medication adherence in adults with type 2 diabetes: the role of early enteral nutrition

Advance Services

Create Content

Video • Presentation • Poster

From $97.00 per format

Abstract

Background: Guidelines make only a weak recommendation on early enteral nutrition. Methods: The primary outcome was medication adherence, assessed blind to allocation. Results: medication adherence occurred in 12% of the intervention group versus 21% of controls. Effects were consistent across prespecified subgroups. Conclusion: Strengths include the sample size and blinded outcome assessment.

Introduction

medication adherence remains a leading cause of avoidable harm among adults with type 2 diabetes. Guidelines make only a weak recommendation on early enteral nutrition.

The cost of medication adherence to health systems is substantial. Practice around early enteral nutrition varies widely between centres.

medication adherence remains a leading cause of avoidable harm among adults with type 2 diabetes.

Earlier studies of early enteral nutrition were small or single-centre. medication adherence remains a leading cause of avoidable harm among adults with type 2 diabetes.

Discussion

Implementation will depend on staffing, cost and local protocols. These findings suggest that early enteral nutrition is associated with better medication adherence in adults with type 2 diabetes.

Strengths include the sample size and blinded outcome assessment. Residual confounding cannot be excluded.

Conclusions

Early enteral nutrition is a reasonable option for adults with type 2 diabetes to improve medication adherence.

References

1. Kaur Z, Moreau C, et al. Early enteral nutrition and medication adherence. BMJ. 2024;87(10):240-1343.

2. Yilmaz S, Costa I, et al. Vitamin D supplementation and acute kidney injury. BMJ. 2019;225(4):67-1480.

3. Zhang J, Tanaka M, et al. SGLT2 inhibitors and health-related quality of life. Lancet. 2021;373(7):453-1314.

4. Larsen W, Farouk Z, et al. A sepsis alert system and length of stay. Pediatrics. 2014;75(9):351-1309.

5. Schmidt J, Kaur V, et al. Telemedicine follow-up and patient satisfaction. Lancet. 2014;186(1):153-982.

6. Nakamura L, Larsen X, et al. Pharmacist-led medication review and glycaemic control. Pediatrics. 2009;393(7):277-1642.

7. Kowalski M, Moreau W, et al. Continuous glucose monitoring and glycaemic control. Diabetes Care. 2023;352(7):488-1188.

Appendices

Ethics approval: IRB-7056.

Materials and Methods

Eligible participants were adults with type 2 diabetes. Missing data were handled with multiple imputation.

Eligible participants were adults with type 2 diabetes. Analyses were adjusted for age, sex and baseline severity.

Eligible participants were adults with type 2 diabetes. Analyses were adjusted for age, sex and baseline severity.

We conducted a randomised controlled trial across 4 centres between 2019 and 2021. Analyses were adjusted for age, sex and baseline severity. Eligible participants were adults with type 2 diabetes.

Results

Effects were consistent across prespecified subgroups. medication adherence occurred in 16% of the intervention group versus 18% of controls. medication adherence occurred in 18% of the intervention group versus 31% of controls.

medication adherence occurred in 12% of the intervention group versus 12% of controls. 2959 participants were included (median age 40 years).

GroupnEventsRate %
Male565356.1
Age ≥ 6546910938.1
Intervention7393932.1
Centre B285814.6
Age ≥ 65669125.6
Control4094725.2
TABLE 1: Secondary outcomes
Values are n (%) unless stated otherwise.
Figure 1
FIGURE 1: Distribution of medication adherence
Shown for adults with type 2 diabetes; error bars are 95% confidence intervals.

Effects were consistent across prespecified subgroups. medication adherence occurred in 15% of the intervention group versus 38% of controls.